EDWARD M. CHEN, District Judge.
In this suit, Ashley Cromwell alleges that Kaiser Foundation Health Plan ("Kaiser") violated ERISA. The action relates to health benefits for Ms. Cromwell's daughter who has autism. Currently pending before the Court are two motions: (1) Kaiser's motion for summary judgment pursuant to Rule 56 and (2) Ms. Cromwell's motion for judgment pursuant to Federal Rule of Civil Procedure 52.
Having considered the parties' briefs and accompanying submissions, as well as the oral argument of counsel, the Court hereby
The following facts are undisputed by the parties.
Covenant Care California, LLC ("Covenant Care") sponsors a health benefits plan for its employees, including Ms. Cromwell. See Compl. ¶ 5. When a claim for health benefits is made under the plan, Kaiser administers and adjudicates the claim. In addition, Kaiser funds any benefits delivered under the plan. See Compl. ¶ 7. During the relevant period, Ms. Cromwell's daughter, who has autism, was covered by the health benefits plan. See Compl. ¶ 5.
There is an agreement between Covenant Care and Kaiser related to the health benefits plan. That agreement is titled "Group Agreement." The Group Agreement is the plan document for the health benefits plan. The Group Agreement incorporates by reference several documents, including but limited to a document titled "Evidence of Coverage."
Under the Group Agreement, Covenant Care delegated to Kaiser "the discretion to determine whether a Member is entitled to benefits under this Agreement. In making these determinations, Health Plan has discretionary authority to review claims in accord with the procedures contained in this Agreement and to construe this Agreement to determine whether the Member is entitled to benefits." Campins Decl., Ex. G (2017-2018 Group Agreement at 6); Campins Decl., Ex. H (2018-19 Group Agreement at 10).
There was a change in the health benefits plan starting on June 1, 2018. That change affected how much Ms. Cromwell had to pay for her daughter's autism speech therapy. Prior to June 1, 2018, Ms. Cromwell paid $20 per visit for the speech therapy, without being subject to a plan deductible. Starting on June 1, 2018, Ms. Cromwell would have had to pay the full cost of the speech therapy up to the amount of the plan deductible ($2,000), after which she would be charged $20 per visit.
Kaiser informed Ms. Cromwell of the change on or about December 18, 2017. In its letter to Ms. Cromwell, Kaiser stated:
Campins Decl., Ex. D (letter). Kaiser stated that the "change [was] being made" because, "[u]nder California Senate Bill 946, physical, occupational, and speech therapy aren't considered mental health services. Consistent with this state law, these services are now covered under your plan's standard physical, occupational, and speech therapy benefits." Campins Decl., Ex. D.
On or about April 5, 2018, Ms. Cromwell wrote to Kaiser, stating, inter alia, that she "strongly disagree[d] with Kaiser's decision to reclassify speech therapy as a non-mental health service. . . . [Her daughter] has a diagnosis of autism, a mental health disorder. Speech therapy is a prescribed mental health treatment for her condition." Campins Decl., Ex. E (letter).
Kaiser responded to Ms. Cromwell on or about April 25, 2018. The response included the following statement:
Campins Decl., Ex. F (letter).
On or about June 25, 2018, Ms. Cromwell wrote to Kaiser again, stating, inter alia, "I have read Senate Bill 946 and am unable to locate any language stating that speech therapy related to autism is not a behavior health treatment." AR 94. Ms. Cromwell further stated: "[L]anguage contained in SB 946 supports speech therapy is intended to be covered as a behavioral health treatment for individuals diagnosed with autism." AR 95 (emphasis in original).
On or about July 25, 2018, Kaiser responded. The response included the following statement:
AR 113.
Subsequently, Ms. Cromwell filed a grievance with the California Department of Managed Health Care ("DMHC").
AR 16.
The California Mental Health Parity Act, codified at California Health & Safety Code § 1374.72, provides in relevant part as follows:
Id. § 1374.72(a) (emphasis added). "The terms and conditions . . . that shall be applied equally to all benefits under the plan contract[] shall include, but not be limited to, [inter alia] [c]opayments." Id. § 1374.72(c)(2). "[T]he stated intent of the Parity Act is simple: to address the imbalance in coverage between mental illnesses and physical illnesses." Rea v. Blue Shield of Cal., 226 Cal.App.4th 1209, 1226 (2014); see also 1999 Cal. Stats. Ch. 534, § 1(b)(2) (finding of the California legislature that, inter alia, "[m]ost private health insurance policies provide coverage for mental illness at levels far below coverage for other physical illnesses").
Senate Bill 946, codified at California Health & Safety Code § 1374.73, addresses pervasive developmental disorder and autism in particular. It provides, inter alia, that
Cal. Health & Safety Code § 1374.73(a)(1).
As an initial matter, the Court notes that, technically, it has two different procedural motions before it: (1) Kaiser's motion for summary judgment pursuant to Rule 56 and (2) Ms. Cromwell's motion for judgment pursuant to Rule 52.
Rule 56 provides that a "court shall grant summary judgment if the movant shows that there is no genuine dispute of material fact and the movant is entitled to judgment as a matter of law." Fed. R. Civ. P. 56(a). An issue of fact is genuine only if there is sufficient evidence for a reasonable jury to find for the nonmoving party. See Anderson v. Liberty Lobby, Inc., 477 U.S. 242, 248-49 (1986). "The mere existence of a scintilla of evidence . . . will be insufficient; there must be evidence on which the jury could reasonably find for the [nonmoving party]." Id. at 252. At the summary judgment stage, evidence must be viewed in the light most favorable to the nonmoving party and all justifiable inferences are to be drawn in the nonmovant's favor. See id. at 255. Where a defendant moves for summary judgment on a claim for which the plaintiff has the burden of proof, the defendant may prevail simply by pointing to the plaintiff's failure "to make a showing sufficient to establish the existence of an element essential to [the plaintiff's] case." Celotex Corp. v. Catrett, 477 U.S. 317, 322 (1986).
Rule 52 concerns, inter alia, findings and conclusions by a court in the context of a bench trial. It provides in relevant part as follows: "In General. In an action tried on the facts without a jury or with an advisory jury, the court must find the facts specially and state its conclusions of law separately." Fed. R. Civ. P. 52(a)(1). In Kearney v. Standard Insurance Co., 175 F.3d 1084 (9th Cir. 1999), the Ninth Circuit indicated that, where there is an ERISA dispute, a trial based on the administrative record alone may be conducted. That is,
Id. at 1095; see also id. at 1094 (stating that "[a] full trial de novo in any ERISA dispute where there was a genuine dispute of fact as to whether the individual qualified for a benefit would undermine" the policies underlying ERISA; "[t]he means that suggests itself for accomplishing trial of disputed facts, while preserving the value of the fiduciary review procedure, keeping costs and premiums down, and minimizing diversion of benefit money to litigation expense, is trial on the administrative record, in cases where the trial court does not find it necessary under Mongeluzo to consider additional evidence").
Whether the Court is considering Kaiser's summary judgment motion or Ms. Cromwell's request for a trial based on the administrative record, the parties agree that the Court evaluates Kaiser's substantive decision to deny benefits for an abuse of discretion. See, e.g., Pl.'s Mot. at 3-4 (asserting that, on a Rule 52 motion, a court determines "whether the adverse benefit decision represented an abuse of discretion").
Stephan v. Unum Life Ins. Co. of Am., 697 F.3d 917, 929 (9th Cir. 2012).
Ms. Cromwell adds, however, and Kaiser does not contest, that the abuse-of-discretion review must be tempered by skepticism because "Kaiser operates under a structural conflict [due to] its dual role as the Plan's administrator and insurer." Pl.'s Mot. at 4 (citing Met. Life Ins. Co. v. Glenn, 554 U.S. 105 (2008)); see also Harlick v. Blue Shield of Cal., 686 F.3d 699, 707 (9th Cir. 2012) (noting that abuse-of-discretion review "is tempered by skepticism when the plan administrator has a conflict of interest in deciding whether to grant or deny benefits"; adding that "[a] conflict arises most frequently where . . . the same entity makes the coverage decisions and pays for the benefits") (internal quotation marks omitted). In Harlick, the Ninth Circuit only applied "some skepticism" because "the record before us does not indicate whether [the insurance company] has a history of bias in claims administration or whether it has taken any steps to promote accurate decisionmaking." Id. at 707-08 (noting that a conflict is given "more weight" where there is such a history and that a conflict is considered "less important" where active steps are taken). In the instant case, the record before the Court does not indicate a history of biased claims administration and reflects at most only limited steps taken to promote accurate decisionmaking (e.g., an internal consultation with a Regulatory Consultant of the Benefits Interpretation and Consulting Department). Accordingly, the Court also applies "some skepticism" in the case at bar.
As an initial matter, the Court addresses Kaiser's contention that Ms. Cromwell's sole remaining ERISA claim, see 29 U.S.C. § 1132(a)(1)(B) (providing that "[a] civil action may be brought . . . to clarify [the participant or beneficiary's] rights to future benefits under the terms of the plan"), should be dismissed because her only position is that Kaiser's actions violate the California Mental Health Parity Act (as incorporated in California Health & Safety Code § 1374.73), which is state law and not ERISA law. Ms. Cromwell has not asserted a separate free-standing claim for violation of the California Mental Health Parity Act (as incorporated in § 1374.73).
In response, Ms. Cromwell makes two arguments:
Ms. Cromwell's first argument is unpersuasive. ERISA's savings clause means that some state claims are not preempted, but that does not mean those state claims are thereby deemed ERISA claims; the state claims are still state claims. Cf., e.g., Harlick, 686 F.3d at 703 (holding that the terms of the insurance plan itself did not require the insurer to pay for the plaintiff's care at a residential treatment facility for her anorexia but that the California Mental Health Parity Act did require such); see also Orzechowski v. Boeing Co. Non-Union Long-Term Disability Plan, 856 F.3d 686, 692 (9th Cir. 2017) ("conclud[ing] that [California Insurance Code] § 10110.6(a) is not preempted [by ERISA] and applies to Boeing's Plan").
The authority cited by Ms. Cromwell is not to the contrary. For example, Aetna Health Inc. v. Davila, 542 U.S. 200 (2004), addresses what happens to a state claim when it is preempted by ERISA (not when it is not preempted). See id. at 209 (stating that "the ERISA civil enforcement mechanism is one of those provisions with such `extraordinary pre-emptive power' that it `converts an ordinary state common law complaint into one stating a federal claim for purposes of the well-pleaded complaint rule'" and, "[h]ence, `causes of action within the scope of the civil enforcement provisions . . . [are] removable to federal court'").
As for Commercial Life Insurance Co. v. Superior Court, 47 Cal.3d 473 (1988), there, the California Supreme Court simply indicated that a statute in the California Insurance Code was preempted by ERISA. The court added that, even if the state statute was "found to be within the scope of the [ERISA] savings clause as a law regulating insurance," the statute would still be preempted because it allowed for remedies not available under ERISA. Id. at 483.
Id. at 484 (emphasis in original). Nothing in Commercial Life indicates that a state claim that is not preempted by ERISA is itself deemed an ERISA claim.
Finally, Townsend v. Thomson Reuters Group Disability Income Insurance Plan, 807 F.Supp.2d 924 (C.D. Cal. 2011), provides at best only limited support for Ms. Cromwell. In Townsend, the defendant moved to dismiss the plaintiff's complaint based, inter alia, "on the fact that Plaintiff is allegedly bringing a cause of action for benefits . . . under [California Insurance Code] Section 10144." Id. at 926 (emphasis added). The court stated that the complaint did "not bring a cause of action for benefits under Section 10144," but rather brought a cause of action for benefits under ERISA, simply using "Section 10144 as the relevant rule of decision here in alleging that Defendants wrongfully terminated Plaintiff's LTD benefits." Id. The court, however, did not address how state law could be a predicate for an ERISA violation. If anything, Townsend provides support for Ms. Cromwell's second argument.
The Court therefore turns to Ms. Cromwell's second argument — i.e., that the plan document in the instant case incorporates state law by reference, thus making state law part of the plan terms and thus providing a basis for an ERISA claim. This second argument presents a close call. In the Group Agreement (which Ms. Cromwell concedes is the plan document), there is a section titled "Governing Law" which provides as follows: "Except as preempted by federal law, this Agreement will be governed in accord with California law and any provision that is required to be in this Agreement by state or federal law[] shall bind Group and Health Plan whether or not set forth in this Agreement." Campins Decl., Ex. H (2018-2019 Group Agreement at 11) (emphasis omitted). According to Ms. Cromwell, "this Agreement will be governed in accord with California law" means that the plan will comply with California law, but there appears to be some ambiguity — i.e., arguably, the sentence simply means that California law applies to the Group Agreement, particularly given the title of the section (i.e., "Governing Law"). For instance, California law may simply affect the Agreement's interpretation or enforceability. On the other hand, it may be argued that under a literal reading, the Agreement incorporates all aspects of applicable California law, including substantive requirements.
For purposes of the pending motions, the Court need not resolve what is meant by the statement "this Agreement will be governed in accord with California law," because, even if Ms. Cromwell should have asserted a separate state law claim (and not just an ERISA claim), the Court could allow her to amend in the state law claim and assert supplemental jurisdiction over that claim. This would be the most efficient way of proceeding given that the parties have been litigating this case for almost a year and the case is now at its end stage. The Court thus addresses the merits of the instant case — i.e., has Kaiser violated the California Mental Health Parity Act ("Parity Act") as incorporated by § 1374.73?
The starting point for the Court's analysis is why Kaiser denied Ms. Cromwell's claim for benefits. As indicated above, Kaiser made three statements regarding its denial of benefits.
As indicated by the above, nowhere did Kaiser assert that speech therapy was not medically necessary for Ms. Cromwell's daughter.
Ms. Cromwell argues that Kaiser violated the Parity Act because speech therapy is a critical part of treatment for autism — that is, coverage for autism is being treated differently from coverage for physical conditions because critical treatment for autism (i.e., speech therapy) costs more as a result of the deductible than critical treatment for physical conditions which are not subject to the deductible. See, e.g., Pl.'s Mot. at 6. ("Kaiser has chosen to treat [autism speech therapy] differently from other in-patient services by making those treatments more expensive than similar types of treatments for physical conditions — indeed, it also treats them differently from other out-patient autism treatments.") (emphasis in original); Pl.'s Mot. at 7 ("[The Parity Act] specifically commands that [autism speech therapy] be provided on the same terms as all other crucial in-patient services for non-mental health, or non-autism conditions."); Pl.'s Mot. at 7 ("[T]he consideration is not between [autism speech therapy] and non-autism speech therapy, but treatment for autism — of which [autism speech therapy] is one of the most useful and prominent — and treatment for physical conditions.") (emphasis in original).
In evaluating whether Kaiser has violated the Parity Act, the Court must first consider the language of the Act. See Baxter v. St. Teachers' Ret. Sys., 18 Cal. App. 5th 340, 356 (2017) (stating that, where the language of a statute is clear, its plain meaning should be followed). The Act provides in relevant part that
Cal. Health & Safety Code § 1374.72(a) (emphasis added). Kaiser literally has complied with the Parity Act because: (1) Kaiser has provided coverage for the medically necessary "treatment" of autism — i.e., speech therapy; and (2) Kaiser has provided the speech therapy on the "same terms and conditions" as applied to all medical conditions. All persons requiring speech therapy — whether for a physical or mental/behavior condition such as autism — must pay the $2,000 deductible before the $20 co-pay process is triggered. Cf. Harlick, 686 F.3d at 712 (stating that "plans that come within the scope of the [Parity] Act must cover all `medically necessary' treatment for `severe mental illnesses,' . . . but can apply the same financial conditions — such as deductibles and lifetime benefits — that are applied to coverage for physical conditions"); see also Doe v. BlueCross BlueShield of Tenn., Inc., No. 2:17-cv-02793-TLP-cgc, 2018 U.S. Dist. LEXIS 126845, at *22 (W.D. Tenn. July 30, 2018) (in addressing claim for disparate impact brought by HIV/AIDS patients against insurer, noting that "plan enrollees who are not disabled yet take specialty medications subject to the Program must endure the same procedural and logistical hurdles that HIV/AIDS patients face[;] [t]his is fatal to Plaintiff's claim because Plaintiff cannot allege that [the insurer] forces HIV/AIDS patients to obtain their medications").
In response, Ms. Cromwell argues that, even though Kaiser formally treats speech therapy for autism and speech therapy for other medical conditions the same, Kaiser's approach more severely impacts treatment for autism than treatment for other medical conditions. This is because speech therapy is a more core component of treatment for autism than for other conditions.
However, Ms. Cromwell's argument is based on an assumption for which she has not provided any substantiating evidence. Cf. Summit Estate, Inc. v. Cigna Healthcare of Cal., Inc., No. 17-CV-03871-LHK, 2017 U.S. Dist. LEXIS 167462, at *30 (N.D. Cal. Oct. 10, 2017) ("Plaintiff's complaint contains no allegation that Defendants provided terms of coverage for mental health treatment different from that of other medical treatment. Again, a health plan violates § 1374.72 [the Parity Act] only if the plan's terms of coverage for treatment of `severe mental illnesses' and `serious emotional disturbances of a child' are different from the plan's terms of coverage for other medical treatments. Plaintiff provides no comparison of the difference in Defendants' terms of coverage for mental health treatment versus other medical treatment."). Although speech therapy may constitute a core treatment for autism, one could equally characterize speech therapy as a core treatment for some patients who have suffered a stroke, physical therapy as a core treatment for someone who has sustained a severe and disabling injury to their nervous system; or occupational therapy as a core treatment for someone who has suffered severe brain injury. Like speech therapy for autism, all of these critical treatments for other medical conditions would be subject to the $2,000 deductible.
Furthermore, the approach that Ms. Cromwell endorses poses extremely difficult, if not impossible, manageability problems. How is a court, let alone an insurer, to determine whether a treatment is "core" or "critical," particularly given a wide assortment of medical conditions? If so, what happens when medical experts disagree? To evaluate parity vis-à-vis autism or other mental/behavioral condition, what medical condition(s) should be used as a comparator? Ms. Cromwell's approach seems to have no logical stopping point. Cf. Alexander v. Choate, 469 U.S. 287, 298-99 (1985) (holding that the Rehabilitation Act's anti-discrimination provision cannot be interpreted "to reach all action disparately affecting the handicapped"; "[b]ecause the handicapped typically are not similarly situated to the nonhandicapped," a broader conception of disparate impact would potentially mean that every policy having an effect on persons with disabilities could trigger liability, and therefore "reject[ing] the boundless notion that all disparate-impact showings constitute prima facie cases under § 504").
In the final analysis, Ms. Cromwell points to nothing in the language or the legislative history of the Parity Act suggesting how the Act applies to an asserted disparity where a policy on its face treats mental and physical conditions equally. Although the DMHC's interpretation of the Parity Act may be entitled to little deference, it is noteworthy that its interpretation is in accord. Nor has Ms. Cromwell pointed to any convincing case authority supporting her interpretation of the Act.
The main case on which Ms. Cromwell relies, Micheletti v. State Health Benefits Commission, 913 A.2d 842 (N.J. Super. Ct. App. Div. 2007), is distinguishable. In Micheletti, although the plaintiff's son's treating physicians prescribed speech and occupational therapy as medically necessary, a state Commission denied benefits for such therapy based on a "contractual exclusion of benefits for non-restorative speech, physical and occupational therapy" — i.e., because "the therapies were sought to develop skills or improve skills that were not fully developed [i.e., previously demonstrated]." Id. at 846, 850 (emphasis added.) The plan totally excluded speech and occupational therapy for autism, while providing such therapy to those suffering, e.g., a stroke. Cf. Rea, 226 Cal. App. 4th at 1236 (stating that "Blue Shield's construction would exclude one of the most effective treatments for anorexia and bulimia [i.e., residential treatment][;] one of the primary legislative purposes of the Parity Act will be thwarted because victims of eating disorders will not receive effective treatment . . . .") (emphasis added). Here, the plan at issue does not totally exclude therapy for autism while providing therapy to other non-developmental physical conditions. The plan formally treats such therapy equally regardless of the underlying diagnosis. Micheletti did not address the question of whether providing facially equal coverage can constitute an unlawful disparity.
The Court acknowledges the hardship imposed upon Ms. Cromwell and her family as a result of Kaiser's change in policy terms. The Court also acknowledges the new policy may seem to impose a singularly burdensome financial cost on patients with autism for whom speech therapy may be so core and important to treatment. But the Court cannot discern anything in the language or legislative history of the California Mental Health Parity Act which prohibits the change Kaiser has implemented. Nor is there an agency interpretation or court decision supporting Ms. Cromwell's asserted application of the Act.
For the foregoing reasons, the Court grants Kaiser's motion for summary judgment. Whether Ms. Cromwell's claim is predicated on ERISA or state law, there is no genuine dispute of material fact that Kaiser did not violate the Parity Act.
As the Court grants Kaiser's summary judgment motion, it must deny Ms. Cromwell's Rule 52 motion.
This order disposes of Docket Nos. 42 and 49. The Clerk is instructed to enter Judgment and close the file.